Documents / Official release

AAWSAP DIRD, Biosensors and BioMEMS: A Survey of the Present Field, March 2010

U.S. Department of War · 2010-03-31 · 45 pages · text from the file's own layer

This Defense Intelligence Reference Document, dated 31 March 2010 and numbered DIA-08-1003-020, was prepared by the Defense Intelligence Agency's Defense Warning Office under its Advanced Aerospace Weapon System Applications Program. It surveys biosensors and biomedical microelectromechanical systems, covering brain-implanted micromachine neuroelectrodes, drug-delivery pumps, glucose sensors, neural interfaces, retinal prostheses, microfluidic lab chips, NASA cell-culture systems and microcantilever sensors. It concludes that the field is expanding rapidly, with nanomechanical systems expected to follow.

From the source:Release of 2026-09-18 Incident: 3/31/10, Las Vegas, Nevada. Released with redactions. This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed. This DIRD surveys biosensors and BioMEMS, a broad class of miniature biomedical devices that combine microscale engineering with sensing, fluid handling, stimulation, or drug-delivery functions. The report reviews major application areas including implantable blood-chemistry sensors, neural interfaces, neurostimulation, drug-delivery pumps, microfluidic systems, and emerging nanoscale extensions of the field, while emphasizing that miniaturization can improve sensitivity and enable functions that are difficult or impossible at larger scales. However, it also makes clear that practical development is constrained by biocompatibility, long-term stability, sensor drift, device degradation inside the body, and the high regulatory burden associated with implantable medical systems. The document presents BioMEMS as a rapidly growing and productive field whose future advances are likely to come through continued improvements in fabrication, materials, and reliability.

UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
The anoChip(R) 400 cartridge ...
oonstructs the user defined pane l of
e c arkers on one chip
Figure 31. Commercial Lab-Chip Devices That Allow Analysis for Biomarkers of Various Diseases Using
on-Chip Electrophoresis in Microscale (collage from manufacturers listed)
These MEMS devices incorporate micro-scale fluidic components, sensors, actuators,
and customized surfaces created by chemical modification or coating with inorganic and
organic materials; enabling tissue engineering and cell patterning studies along with the
microfluidic control of the culture environment.
NASA SPACE APPLICATIONS FOR MICROFLUIDIC SYSTEMS
NASA has supported at Arizona State University, the development of new types of
microfluidic systems directed towards growing cell cultures on a chip. The specific
application is detecting the effects of space flight and microgravity on living things at
the cellular scale.
Space presents a number of stresses on the cells of the astronaut's body from
electromagnetic fields, microgravity, and space cabin environments, which in
combination have effects that are likely different than any single stress. Beyond
affecting the astronaut directly, space flig ht can change any organism, and actua lly
makes some bacteria more dangerous.
Cells can be grown to represent the cells of the astronaut's body. Changes in DNA
expression or molecular stress markers in cultured cells can be used to infer effects of
space.
Culturing mammalian cells in the laboratory generally requ ires constant attendance and
adjustment, but astronauts have little time for routine culture procedures. Thus NASA
supported the desig n of an automated microfluidic system to perform all the steps
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
34

Not linked to a story yet.

About this file

Official release, from the pursue collection. The PDF is mirrored here; the original link is above. 45 pages are in the text index: search them above, or from the library's search.